The most recent appropriations for the Department of War expired at 11:59 p.m. EST on September 30, 2025. Military personnel will continue in a normal duty status without pay until such time as a continuing resolution or appropriations are passed by Congress and signed into law. Civilian personnel not engaged in excepted activities will be placed in a non-work, non-pay status.

If you have a scheduled appointment or other business at the MTF, please verify with your provider or applicable office within the MTF to ensure there are no changes in schedule. To learn how the lapse in appropriations affects your TRICARE benefit, visit www.tricare.mil/shutdown

News & Gallery

Articles

Results:
Tag: Oncology

"Unprecedented Cancer Treatment Emerges on the Military Medical Front" In the fight against aggressive lymphoma cancer, the Hematology/Oncology team at the Alexander T. Augusta Military Medical Center (ATAMMC), under the leadership of Dr. Pramvir Verma, introduced a pioneering solution - Epkinly, a monoclonal antibody anticancer medication used for the treatment of diffuse large B-cell lymphoma. Unveiled at ATAMMC, it serves as a beacon of hope for patients who have not responded to previous treatments.

May 3, 2024

Pioneering Cancer Therapy: Unveiling New Possibilities in Military Health

FORT BELVOIR, Va. — "Unprecedented Cancer Treatment Emerges on the Military Medical Front" In the fight against aggressive lymphoma cancer, the Hematology/Oncology team at the Alexander T. Augusta Military Medical Center (ATAMMC), under the leadership of Dr. Pramvir Verma, introduced a pioneering solution - Epkinly, a monoclonal antibody anticancer medication used for the treatment of diffuse large B-cell lymphoma. Unveiled at ATAMMC, it serves as a beacon of hope for patients who have not responded to previous treatments.

Don't forget to keep your family's information up to date in DEERS!